Norges Bank Holds Key Rate at 4.5%, First Cut Expected at Beginning of 2025
By Dominic Chopping
Norway's central bank held its key policy rate at 4.5%, a level that is expected to remain unchanged until the end of the year as a weak krone continues to threaten efforts to bring inflation down.
The decision was in line with a Wall Street Journal poll.
The policy rate has been at 4.5% since December 2023 and has helped slow inflation significantly from its peak, but underlying inflation hasn't declined to the same extent, while a rapid rise in business costs and the krone's depreciation will likely restrain further disinflation, the bank said Thursday.
"We believe that there is a need to keep the policy rate at today's level for a period ahead but that the time to ease monetary policy is approaching," said Governor Ida Wolden Bache.
Norges Bank said its new forecast implies the policy rate will remain at 4.5% to the end of 2024 before being gradually reduced from the first quarter of 2025. The forecast is little changed from its previous forecast in June but the bank said it now expects a slightly faster decline in the policy rate through 2025, falling to 2.7% at the end of 2027.
Inflation is projected to approach 2% toward the end of 2027, it added.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
September 19, 2024 04:43 ET (08:43 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk